Triton Wealth Management’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-31
Closed -$93K 108
2020
Q4
$93K Sell
31
-68
-69% -$25.4K 0.06% 87
2020
Q3
$37K Buy
99
+49
+98% +$19K 0.03% 78
2020
Q2
$23K Buy
+50
New +$12.6K 0.02% 82

Other funds holding BNGO

Triton Wealth Management's BNGO Position: Q1 2021 in Review

Triton Wealth Management sold out of Bionano Genomics (BNGO) in Q1 2021, closing a stake of 31 shares — an estimated $93K sold.

Triton Wealth Management first reported a position in BNGO in Q2 2020 and held it in 3 quarters. The position peaked at $93K in Q4 2020. 109 funds tracked by Wall St. Rank hold BNGO as of Q1 2021.

  • Triton Wealth Management reported no remaining Bionano Genomics position as of Q1 2021 after selling out during the quarter.
  • Triton Wealth Management sold 31 Bionano Genomics shares in Q1 2021, an estimated $93K.
  • Triton Wealth Management first reported a position in Bionano Genomics in Q2 2020 and held it in 3 quarters.
  • Triton Wealth Management's Bionano Genomics position peaked at $93K in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2021.

Based on Triton Wealth Management's 13F filing for Q1 2021, filed 19 Apr 2021.